Further mechanistic studiesrevealed that lnc-ITSN1-2 functions as a competing endogenous RNA(ceRNA) by directly binding to miR-125a to upregulate IL-23R expression.Through this regulatory pathway, lnc-ITSN1-2 modulates CD4 T cellfunctions in IBD. The gene discussed is CD4; the disease is irritable bowel syndrome.